Sanochemia utilises its entire value chain in order to implement appropriate market development strategies. The aim here is to identify approaches which will lead to an increase in the value of the company. This includes expansion into growing pharmaceutical markets, so-called pharmerging markets, as well as the development of core markets such as Germany and the future development of the US and Chinese markets. In addition, the company is continuously working on expanding its product portfolio in order to achieve greater market penetration.
Joint development with partner companies, employees and the region is an essential cornerstone of the company’s business activities. The company sees itself as a driving force for the region.
The current Covid-19 pandemic opens up particular strategic potential for Sanochemia in its home market: the company is one of the few companies in Austria to have maintained production, technology and know-how in Europe at all times.
As a manufacturer with an all-purpose production facility for APIs, SANOCHEMIA can make a significant contribution to domestic security of supply of critical pharmaceuticals.
In addition, we use resources, experience and knowledge relating to quality assurance and GMP requirements, as well as space to support other companies. With GMP Services and the SANOCHEMIA GMP Campus, external companies benefit from the proximity to a high-quality pharmaceutical environment.